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Abstract 
This study was conducted in Neonatal intensive care unit (NICU) of a teaching 
hospital of JNMC, Aligarh to estimate the incidence of nosocomial infection (NI). 
Gram-negative bacilli are frequently associated with NIs in NICU patients, 
particularly ventilator-associated pneumonia and catheter-associated urinary tract 
infection. During one-year study period from January 2006 to February 2007, 
samples were collected form different source like blood, catheter, urine, surface, 
eyelid, mouth, cerebrospinal fluid (CSF), pus and environment. These isolated 
bacteria from NICU were identified on the basis of morphology. Gram staining, 
motility and capsule staining, through different types of biochemical (NB, BHI, 
and EMB agar), finally sample were cultured on MacConkey agar. E.coli isolates 
were identified as non capsulated, motile, circular, convex, and smooth colonies 
where as Klebsiella spp appeared as pink colonies, large, very mucoid, capsulated, 
non-motile on the other hand Pseudomonas spp were motile, rods which produce 
water soluble green or yellow green (fluorescing) pigments. These clinical isolates 
were further characterized by standard biochemical tests. Gram-negative bacilli 
are frequently associated with NIs in NICU patients; particularly ventilator-
associated pneumonia and catheter associated urinary tact infection. 
During the period of one year, a total of 3513 neonates were screened for 
the NIs in the NICU. Among these 3513 of neonates 973 (27.69%) were found to 
have clinically suspected cultures. While 30.72% (299/973) of them were positive 
for neonatal infection. The over all 178 (65.68%) neonatal sepsis were found to 
comprised of 26.93%, 14.39%, 10.70%, 8.85%, 2.58% 2.21%, UTI, septicemia, 
conjunctivitis, throat, pus, and meningitis infection respectively. Among 271 
isolates, 66 (24.35%) cases of intracath and 27 (9.96%) surface culture were 
found. The causative organisms of intracath and surface culture were found to be 
predominantly, Klebsiella followed by E.coli and Pseudomonas spp. 
Of, 271 confirmed isolates of neonatal infection, 27.30% (74/271) were 
confirmed as E.coli, 191 (70.74%) were Klebsiella spp and 6 (2.21%) were 
Pseudomonas spp. Moreover the study also revealed that a total of 186 neonates 
out of 271 (68.63%) were categorized as very low birth weight babies (<1500g) 
where as 85 of them were belong to the low birth weight babies (>1500g <2.5g). A 
total of 164 (60.51%) cases of preterm babies (<37 weeks) were found in this 
study (164/271), remaining were fiill term (>37 weeks) babies (39.48%). We have 
also screened the environmental sample collected from different sites from NICU 
more found to have 28 (9.36%) isolates of E.coli, Klebsiella and Pseudomonas 
spp. 
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Introdkiction 
Nosocomial Infections (NIs) are important contributors to morbidity and 
mortality because of more frequency of impaired immunity (age, illness, 
treatment), new microorganism and increasing number of people, as well as 
increasing bacterial resistance to antibiotics (Ducel. 1995) Most organisms 
causing NIs usually come from the patients' own body (endogenous flora). 
They also can come from contact with staff (cross-contamination), 
contaminated instrument, needles and the environments (exogenous 
flora)(Alvarado, 2000). 
The term "nosocomial" comes from two Greek words: "nosus" 
meaning "disease" and "Komeion" meaning "to take care o f . Hence, 
"nosocomial" should apply to any disease that comes to patient while the 
patient is under medical care. However the term "Nosocomial" has been used 
over the years now just refers to hospitals acquired infection. A nosocomial 
infection is one that is acquired in the hospital or long term care facility. In 
general, NIs are more serious and dangerous than community acquired 
infection because the bacteria in hospital are more resistant to typical 
antibiotics (Lynch..et.al., 1997). Since antibiotics have come in to common 
usage and the microorganisms that are resistant to them have also become 
common, especially in hospitals. 
In USA, for instance, 50-60% of > 2 millions NIs are caused by 
antibiotic resistant pathogens. Over all national prevalence rate have been 
described as ranging between 3.5 and 9.9 %( Gastmeier, 1998) . But they are 
varying between department patients group and the overall infection rate 
ranges from 8.9 to 62 infections per 1000 patient or 25% of neonatal intensive 
care unit (NICU) population. As would be expected that greatest variation be 
related to site-specific infection rate by birth weight. NIs may not only be 
related to the patient primary disease process but also directly related to action 
of health care workers. The most common intervention associated with 
infection was the use of intracath and its main object is to change in hospital 
demographics among hospitals participating in the Center for Disease Control 
and Prevention (CDC&P) and National Neonatal Intensive Surveillance 
(NNIS) system. Data from NNIS shows a 17% increase in the number of NICU 
beds at the hospitals from 1988 to 1995, however the total hospital beds 
capacity has decreased (Scott, 1999). Secondly, patients who receive care in 
NICU are at increased risk for NIs especially for pneumonia, and blood stream 
infection during the past 20 years. 
Spread of nosocomial infection in NICU 
The rate of NIs markedly higher in many developing countries, especially 
those infections that are largely permeable and follow the surgical procedures 
such as cesarean section. In these countries, NIs rate are higher because of lack 
of supervision, poor infection prevention practices and inappropriate use of 
limited resources and over crowded hospital (Emori and Gaynes, 1993). NIs 
typically spread by medical or surgical treatments. Ageing of our population 
and increasing aggressive medical and therapeutic interventions including 
implanted foreign bodies, organ transplantation and xenotransplantation have 
created a cohort of vulnerable persons. As a result, NIs rate in NICU is 
approximately three times higher than elsewhere in the hospitals. The site of 
infection and the pathogens involved are directly related to treatment in the 
NICU. The NIs are generally spread through contamination that is state of 
having been actually or potentially in contact with microorganism. As used in 
health care, the term 'contamination' generally refers to the presence of 
microorganism that is capable of producing disease or infection. It may be 
either laboratory acquired by means of laboratory activities by staff, regardless 
of how it occurred or hospital acquired. However, occupational injuries or 
infections acquired by health care staff while performmg their duties (Black, 
1996) have the great importance in this regard. The contributing factors are; 
substandard practice for separating blood transfiision services, increasing use 
of invasive medical devices without proper training or laboratory support, use 
of contaminated intravenous fluids, antibiotics resistance due to overuse of 
broad spectrum antibiotics, unsafe and frequently unnecessary injections. 
The contributing factors are inadequate standards and practices for 
operating blood transfusion services; increase use of invasive medical devices 
(e.g. mechanical ventilators, urinary catheters and central intravenous lines etc) 
without proper training or laboratory support; use of contaminated intravenous 
fluids especially in hospital making antibiotics resistance due to over use of 
broad spectrum antibiotics and unsafe and frequently unnecessary injection. 
More than 50 % of injections in developing countries are unsafe (Simonsen, 
1999). NIs are significant problem through out the world (Robert et.al, 2006). 
In 1987, a prevalence survey involving 55 hospitals in 14 developing countries 
in four WHO region (Europe, Eastern Mediterranean, South East Asia and 
Western Pacific) foimd in average of 8.7% of all hospital patients had NIs. 
Thus at any time, over 1.4 million patients world wide will have infections 
acquired complication in the hospital (Tikhomirov, 1987). However, because 
of progressively shorter in patients' stay over the last 20 years, the rate of NIs 
per 1000 patient per days actually increased 36% from 7.2 in 1975 to 9.8 
inl995. It is estimated that in 1995 NIs cost $ 4.5 billion and contributed to 
more than 88000 deaths (Samuel et.al, 2002) . These infections are the second 
most frequent adverse effect of hospitalization (StoU et.al, 1996). 
Hospital acquired infection in NICU is a significant cause of mortality 
and morbidity, particularly in very low birth weight (VLBW, <1500 g) babies. 
VLBW infants when affected by these infections are at increased risk for 
death, have a longer hospital stay, and utilize more resources than unaffected 
controls (Stoll et.al,20Q2). The 15 participating centers in the National 
Institute of Child Health and Human Development Neonatal Research Network 
found that 11% to 32% (mean 21%) of VLBW infants have at least one 
episode of nosocomial sepsis (Robert et.al, 1998). Similar variations have 
been described in other data sets (Robert, 1998; Brodie, 200). These studies 
also showed that valid comparisons of rate of nosocomial sepsis between 
centers require adjustment for risk factors, such as patient demographics and 
admission illness severity. Risk-adjustment has also been used to look at 
variations in rates of both neonatal mortality and morbidity (Horbar et.al, 
1997), For example, it has been shown that, after correcting for a number of 
confounders, Canadian NICUs vary significantly in their rates of death, 
catheter-related sepsis and intraventricular hemorrhage (Sankaran, 2002, Chien, 
2002 and Synnes, 2001). Each of these authors concluded that differences in 
outcome might be partly attributable to practice variation. 
The concept of NICU came into existence in the developed world in the 
mid 60's and 70's with the availability of excellent material and child health 
services (Safdar et.al.,20^\). Resulting with survival of practically all normal 
newborn, their attention was then focused on improving survival rates in the 
high risk groups of new bom like very low birth weight babies especially those 
with problems like hyaline membrane disease. 
NICU is a unit that provides high quality skilled care to critically ill 
neonates for continuous clinical and radiological monitoring and use of life 
support system with the aim of improving survival of these babies (Edwards, 
2002). As the treatment of many patients shift from the hospital setting to 
home or other alternatives health care setting, health care delivery in the NICU 
continues to face new and difficult challenges. First, this shift in patient care 
has caused an increase in the severity of illness among the patients receiving 
care in the hospital compared with hospitalized patients of the previous decade. 
The etiology of acquired infections in NICUs is multifactorial (Singh et.al, 
1996). with risk arising from the factors attributable to the host, the organism, 
the envirorunent and clinical interventions. However, previous studies only 
examined risk factors for hospital-acquired infections in VLBW infants. It is 
unclear whether risk factors are different in larger infants with 1500 g or higher 
birth weights (HBW) admitted to the NICU. 
Emerging Nosocomial Infections 
Streptococci are the cause of most NIs problems. For the past 50 to 60 years, 
Gram-positive cocci, particularly Streptococci and Staphylococcus aureus were 
hospital pathogen of major concern. In 970s, Gram-negative bacilli particularly 
Pseudomonas aerugenossa and Enerobaceteriaceae, became synonymous with 
NI. In late 1980s and early 1990s, several different classes of antimicrobial 
drugs, effective against Gram-negative bacilli provided a brief respite (New 
York Time, 1998). During this time, methicilline resistant S. aureus (MRSA) 
and vancomycine resistant Enterococci (VRE) emerged, signaling the return of 
the "blue bugs". In 1990 to 1996, the three most common Gram positive 
pathogens; S aureus, coaglase negative Staphylococci, Enterococci and the 
four most common Gram negative pathogens; E.coli, P.aeruginosa, 
Enterococci spp, K.pneumoniae accounted for 34% and 32% of NI, 
respectively. (Haley et.al., 1985). However, tracking NIs by site has become 
difficult in the last few years due to shorter duration of patient's stay. For 
example, the average postoperative stay, now approximately 5 days, is usually 
shorter than the incubation period for S. aureus surgical wound infection, 
which is 5 to 7 days (Culver, 1991). 
Acquired antimicrobial resistance is the major anticipated problem in hospital. 
VRE and MRSA are the major gram-positive pathogen of great concern 
(Slaughter et.ai, 1996 and Bonten et.al., 1996). P. aeruginosa, Klebsiella and 
Enterobactor that harbor chromosomal or plasmid mediated beta lactamase 
enzyme are the major resistant grsmi-negative pathogens. The contribution of 
antibiotic resistance to excessive death rate in hospitals is difficult to evaluate 
often depending on whether studies are population based or case control but 
there are enough evidence that indicate the antimicrobial resistant role in 
noscomial deaths. As bacterial resistance is a major threat, however, viral and 
fungal resistance may be more important because of the small number of 
therapeutic option for these pathogens. Since, we are facing the era of 
opportunists that also include fiingi, viruses and parasites in 
immimocompromised patients, the one we are fear most in the post antibiotic 
era. The first nosocomial inkling is MRSA with reduced susceptibility to 
vancomycine (Hiramatsu et.al, 1997). Beyond the post antibiotic era lies the 
era of exogenic infections as organs, transplanted from non-human primates, 
bring with them a variety of potential zoonotic pathogens. Nevertheless, 
tradition respiratory pathogens may yet to be proven to be our greatest 
challenges. For example, a major shift in strain types (Webster, 1998) could 
result in devastating pandemic community and noscomial influenza an out 
breaks. 
Prevention and Control of Noscomial Infection 
For prevention and control of NIs, it is necessary to improve the national 
surveillance program that represents a comprehensive and valid data and 
thereby one can assess the sensitivity and specificity of NIs surveillance and 
case definition (Goldman, et.al, 1996). Secondly, it should be ensured that 
the sources of NIs like use of invasive devices in NICU patients should be 
controlled by designing a better device. Simultaneously, aggressive antibiotic 
control programs also will be required to control the NIs. However, 
investigation of outbreaks of multidrug resistant pathogens pulsed-field gel 
electrophoresis and molecular epidemiological analysis also may help a better 
understanding to the factors of emerging restraint strains. 
Patients were suspected to have developed NIs after 48 hours of 
admission to the NICU were collected all the sample like blood, catheter tip, 
urine, surface, eyelid, mouth, cerebrospinal fluid (CSF), pus, and 
environmental (ventilator, radiant wormer, phototherapy, cot, stethoscope, 
refrigerator weight machine) cultures or those developing clinical sepsis within 
72 hours of birth were diagnosed to have pathogen. Neonates were considered 
to be at risk of developing sepsis if any one of the following potential maternal 
risk factors were present - prolonged rupture of membranes for >24 hours, foul 
smelling liquor, dai (midwife) handling, maternal urinary tract infection within 
2 weeks prior to delivery or peripartum fever. 
Mechanisms of drug resistance 
The past few decades have been an alarming increase in the prevalence of 
resistant antimicrobial pathogens in serious infection. In the USA, for instance, 
50-60% of >2 millions of NIs are caused by antibiotic resistant pathogens. 
Furthermore, the prevalence of antibiotic-resistant pathogens isolate in the 
NICU setting may be significantly higher then in other hospital wards (Weber, 
et.al, 1999). Infections caused by resistant pathogens represent an important 
source of morbidity, mortality and increased costs. 
The antimicrobial resistance is a natural biological phenomenon of 
response of microbes to the selective pressure of an antimicrobial drug ( 
Sharma Rashmi, et.al, 2005 ), Changing the health care infection, infection 
control practice, antibiotics use and resistance may influence the frequency that 
these gram-negative organisms are associated with hospital-acquired infection 
(Robert, et.al, 2005), Resistance may be inherent, which explain the 
phenomenon of opportunistic infection or acquired concern about the 
resistance increased in the late 1990s and since then, many governmental 
report have been published, advising the less use of antimicrobial agents, 
appropriate use of antimicrobial therapeutic regimens, prevention of cross 
infection and development of new antimicrobial agents 
The rapid emergence of multi drug resistance (MDR) strains of gram 
negative and gram positive bacteria are the more worrisome problem in the 
present therapeutics scenario. Persistence of MDR can be overcome by 
modification of dosage regimens (e.g. using high dose therapy) or inhibiting 
the resistance mechanism by using an agent belonging different class. 
Drug resistance can be described as a state of insensitivity or decreased 
sensitivity to drugs that ordinarily cause growth inhibition or cell death. This 
phenomenon has been recognized since the latter part of the 19*" century in the 
microorganism and more recently in mammalian cell in vitro and in cancer 
cells in vivo. The discovery of antimicrobial agents by Paul Ehrlich was one of 
the most remarkable discovery, that changed the face of medical practice 
(Wood, et.al.,2003) However, the increased global flow of antimicrobials 
brought with it the threat of antimicrobial resistance. Concern about the 
resistance increased in the late 1990s since then, advising less use of 
antimicrobials, appropriate choice of antibacterial and regimens, prevention of 
cross-infection and development of new antibacterial. As antimicrobials are 
frequently misused and overused in many developing countries, thus resistance 
to antimicrobials has led to an increase in morbidity, mortality and cost of 
health care. To maintain the useful life of antimicrobial drugs in the developing 
countries there is need to improve access to diagnostic laboratories, improved 
surveillance of the emergence of resistance, better regulation of the use of 
antibiotics, and better education of the public and doctors in the appropriate 
usage of the drug. 
Resistance may be inherent, which explains the phenomenon of 
opportunistic infection or acquired (Barker, 1999). Anaerobic bacteria, 
Enterococcus species are inherently resistant to amino glycosides, 
Pseudomonas species to tetracycline. Gram-negative bacteria to glycopeptides 
and Gram-positive bacteria to azotreoname (Bonfiglio,e/.a/., 2002). Mutation 
or gene transfer can develop acquired resistance. Gene transfer can occur 
through transformation, transduction and conjugation. Mutation may occur in 
the gene encoding target protein, transport protein, protein for drug activation 
or promoter or regulatory gene affecting expression of the target transport 
protein or an inactivation enzyme (Rang, et.al, 2004). Production of Beta-
lactamases by the bacteria is the most important mechanism associated with 
beta-lactam antibiotic resistance. There are over 200 types of beta-lactamases. 
Moreover, for many antibiotics including beta-lactam group, the primary 
means of transport across the outer membrane of enteric bacteria are a 
remarkable group of plasma proteins called as porins. Three major porins have 
been identified in E.coli, namely (a) Larger porin channel outer membrane 
porin F (Omp F) (b) Small porin channel porin C (Omp C) (c) Pho E (present 
in mutants and of no significance in antibiotic movement) Factors like the 
charge on the molecule and hydrophobicity of the compound also play an 
important role in the transport of drug molecules. The negatively charged 
molecule like methicillin hang up in the negatively charged porin channel of 
Gram-negative bacteria; where as beta-lactam antibiotic having long side chain 
(piperacilin, ceftazidime) can also cross the membrane poorly, except 
imipenem with compact structure. The energy dependent efflux mechanism is 
a prime defense for bacteria against tetracycline, quinolones and 
macroUdes)(Koneman, et.al,\991). P-glycoproteine transports a wide range of 
drugs like rifampin, sparfloxacin etc. 
The past few decades have seen an alarming increase in prevalence of 
resistant antibacterial pathogens in serious NIs. The NICU is burdened with a 
high frequency of NIs often caused by MDR (Christina, 2004) which causes a 
world wide increased morbidity length of hospital stay, mortality and the 
pathogens isolated in the NICU setting may be significantly higher in other 
unit of hospital. They are also an indicator of the quality of hospital care over 
more important as a public health problem with increasing economic and 
human impact. It might be debated that NIs in NICU environment are 
unpreventable in attempts to keep the smallest and sickest of babies alive. 
Some researchers believe that NIs may be unavoidable even under the most 
optional infection in the most vulnerable patients. 
Subjects 
Patients were suspected to have developed NIs after 48 hours of admission to 
the NICU if they had (/) unexplained fever >38°C, leukocytosis>10000/mm3; 
(«) new infiltrates on chest X-ray, persistent tracheal aspirates or secretions; 
{Hi) turbid urine, suprapubic tenderness, dysuria, burning micturition;(/v) 
thrombophlebitis; or cloudy effluent containing more than 100 
polymorphonuclear cells/mm3, abdominal pain or tenderness or 
microorganisms in peritoneal dialysis fluid. Those having fever prior to 
admission to the NICU, or any other clinical features of infection secondarily 
acquired in the wards prior to transfer to the NICU were excluded. Relative 
frequencies of known risk factors like age, anemia, malnutrition, severit\ of 
disease and duration of NICU stay were studied in patients who developed NIs. 
Detailed clinical examination of all patients taken up from NICU for the study 
was done daily (Craven, et.ai, 1998). Specific site related investigations 
included: 
• Gastric lavage, sputum, conjectivital, throught, body surface (skin) CSF 
(cerebrospinal fluid) and pus samples were taken by sterile cotton swabs 
aseptically were cultured in nutrient broth (NB). 
• Blood culture in brain heart incision (BHI) at the time of admission to rule 
out an already existing infection and as and when patient developed clinical 
features suggestive of an infection. 
• Intravenous catheter were cultured in those with suspected thrombophlebit is 
along with simultaneous blood culture from a site different from the site of IV 
catheter after preparing the site with 70% alcohol and 1% betadine. 
• Urine and tips of indwelling catheters were cultured simultaneously in 
patients with suspected urinary tract infections. 
Standard CDC criteria 1988 were used to differentiate colonization from 
infection (Camer, ef.a/., 1988). The same criteria were also used to define 
nosocomial respiratory, urinary and catheter related infections. Bacteriological 
culture was done using standard microbiological methods. Environmental 
sampling was done on a random basis from stethoscopes, cots, radiant warmer, 
phototherapy, refrigerator, weight machine, ventilator tubing, cradles, suction 
pumps and oxygen catheters. For each type of catheter related infection, 
different risk factors were studied e.g., type and duration of the catheter in situ, 
duration and indication of mechanical ventilation, etc. We used the CDC 
definitions for NIs that appeared in a report by Gamer et.al., 1988. They were 
as follows. 
Symptomatic urinary tract infection (UTI). 
Patients received a diagnosis of symptomatic UTI if 1 of 2 criteria were met. 
According to criterion 1, (a) at least one of the following signs of symptoms 
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must be present with no other recognizes cause: fever (temperature, >38°C), 
urinary urgency, high frequency of urination, dysuria, and/or suprapubic 
tenderness; and (b) resuhs of urine culture must be positive (defined as > 105 
microorganisms/ml of urine, with no more than 2 species of microorganisms 
per patient). According to criterion 2, (a) at least 2 of the following signs or 
symptoms must be present with no other recognized cause: fever (temperature. 
> 38°C) urinary urgency, high fi-equency of urination, dysuria, and/ or 
suprapubic tenderness; and (b) at least one of the following characteristics 
must be present: detection of organisms in imcentrifuged urine by Gram stain, 
at least 2 urine cultures positive for the same type of uropathogen (either gram 
negative bacteria with 102 or more colonies/ml in nonvoided urine specimens), 
detection of no more than 105 colonies/ml of single type of uropathogen (gram 
negative bacteria) in cultures of urine specimens obtained from patients 
receiving treatment for a UTI with an effective antimicrobial agent, physician 
diagnosis of urinary tract infection, and/or physician initiation of appropriate 
therapy for urinary tract infection. 
Laboratory-confirmed bloodstream infection (BSI). 
Patients with a central venous catheter (CVC) received a diagnosis of 
laboratory-confirmed BSI if one of two criteria were met. According to criteria 
1, one or more blood cultures must yield a recognized pathogen that is not 
related to an infection at another anatomical site. According to criteria 2, (a) at 
least one of the following signs or symptoms must be present: fever 
(temperature, > 38°C), chills, or hypotension; and (b) at least one of the 
following conditions must be met: growth of a common skin contaminant in 2 
or more cultures of blood drawn on separate occasion; in at least one culture of 
blood obtained from a patients with an intravascular line and physician 
initiation of appropriate antimicrobial therapy; and or a positive result of 
laboratory test unrelated to an infection at another site. 
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Clinical sepsis. 
Patients with a central venous catheter (CVC) in place received a diagnosis if 
the following three criteria were met:(l) at least one of the following clinical 
signs or symptoms were present with no other recognized cause: fever 
(temperature, > SS^C), hypotension (systolic blood pressure, < 90 mmHg), and 
or oligosuria (urine production, < 20ml / hour);(2) blood culture was 
performed, no organisms were detected in blood cultures, or no apparent 
infection was detected at another site; and (3) a physician initiated treatment 
for sepsis. 
Pneumonia. 
Patients received a diagnosis of pneumonia if the following 2 condition: at 
least one of the following signs and symptoms were present: fever 
(temperature, > 38°C) with no other recognition cause leucopoenia (leukocyte 
count, <4,000 WBCs/mm^) or leukocytosis (leukocyte count, > 12,000 
WBCs/mm^) and (2) at least 2 of the following signs and symptoms were 
present (a) new onset of purulent sputum, change in character of sputum, 
increased quantity of respiratory secretion, or increased suctioning 
requirement;(b) new onset or worsening cough, dyspnea, or tachypnae (Cook, 
et.al, 1998). (c) rales or worsening gas exchange (Gastmeier et.al, 1998), 
such as O2 de-saturation (e.g., a ratio of the partial pressure of O2 to the 
fraction of inspired O2 that is 240 or less), increased oxygen requirement, or 
increased ventilator demand. 
In view of the present background we initiated our study to examine (a) 
risk factors for culture-proven hospital acquired infections for VLBW and 
HBW infants admitted to the NICU, (b) the risks associated with specific 
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clinical interventions in the NICU and (c) the risk-adjusted variations in 
hospital acquired infection rates among J.N.M.C, Aligarh in NICUs. 
MateriaC 
And 
Metfiods 
Chemicals 
Nutrient Broth (NB), Eosin Methylene Blue (EMB), Brain Heart Infusion 
(BHI), MacConkey Agar and methyl red were purchased from Hi Media 
chemicals (India). D-Glucose, Lactose, Maltose, Sucrose, Manitole, Ehrlichs 
reagents, a-naphthylamine, and a-naphthol were purchased from SRL 
chemicals, India. Rest all chemicals used was of analytical grade. 
Bacterial strains 
All bacterial strains used in this study were isolated from clinical specimens. 
During one-year study period from January 2006 to February 2007. Bacteria 
were grown at 37°C in NB and BHI. All media were used after autoclaving it at 
12rC at 151b/in2 for 15-20 min. 
Clinical specimens 
Samples were collected from 973 nosocomial active subjects from the neonatal 
intensive care unit (NICU) Department of pediatrics, J.N.M.College, AMU, 
Aligarh during one-year study period from January 2006 to February 2007. 
Sample (conjunctivitis, body surface, throught, nasal swab) were taken by a 
cotton swab, urine, catheter were inoculated in Nutrient broth (NB) and blood 
sample were inoculated in Brain Heart Infusion (BHI). Each sample after 
overnight incubation at 37°C was transferred to selective media. 
Selective media. 
All clinical isolated were cultured on MacConkey Agar and incubated at 37 °C 
for 24 h. They were identified on the basis of morphology as E.coli, Klebsiella 
and Pseudomonas by their characteristic appearance on the media. 
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Gram staining 
Pure culture of each isolate was processed ftxrther for identification. A colony 
from MacConkey was spread on a slide. The smears heat fix over flame, it was 
stained by crystal violet for Imin, washed with tap water followed with iodine 
for Imin, washed with tap water and blot dry. Decolorized with 95% ethyl 
alcohol for about 30 seconds gently agitated the slide till no colour comes out 
from the smear. Blot dry. Counter stain for about 10-20 seconds with safranin 
solution. Washed with tap water, dried and examined under microscope 
(Malik, 1995). 
Motility test (hanging drop method) 
Small drop of liquid bacterial strain were placed on the cover slip. Invert the 
microslide having a layer of Vaseline around the depression, over the coverslip 
allowing the glass to adhere to the Vaseline. Quickly turn the slide upside 
down so that the coverslip is uppermost. The slide was placed on the stage of 
the microscope and examined. Bacterial motility was distinguished from 
Brownian movement (Malik, 1995). 
Capsule staining 
Capsule is an outer structure of bacteria. Its thickness varies greatly in 
different species of bacteria. Small drop of Indian ink were placed on a slide. 
Small loopflil bacterial culture was mixed properly. Cover glass was placed 
over the drop (avoids air bubbles and press firaily between blotting paper). It 
was examined under high magnification (Malik, 1995). 
Carbohydrate fermentation test 
Solution A and B were prepared separately. Andrade's indicator (see appendix) 
was added to solution B in 1% strength and mixed thoroughly. The pH of 
solution B was adjusted to 7.4 and dispense in sterile sugar tube in 2.5 ml 
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quantity. Solution A and B were sterilized in tubes at 115°C for 20 minutes in 
autoclave. 25ml of solution A in each peptone water (solution B) tube to make 
1% sugar medium, inoculate one tube of each sugar with 2 drops of bacterial 
strain. After incubating at 37°C for 24 hours (Collins and Lynes, 1989). 
Indole test 
Few colonies of bacterial isolates from MacConkey were inoculated in peptone 
water. After incubating at 37°C for 48 hours 1ml of ether was added to 5 ml 
test culture, ft was shaked well and allowed to stand, till the organic solvent 
comes to surface of the medium to get the characteristic ring form. One ml of 
Ehrlich reagent were run down (see appendix) by the side of the tube and 
watch for the development of deep red colour (Collins and Lynes, 1989). 
Methyl red test 
This test was employed to detect the production of acid during the fermentation 
of glucose and the maintenance of pH below 4.5, produce acidity. Few 
colonies of bacterial isolates from MacConkey were Inoculated in glucose 
phosphate broth and incubate up to 5 days at 30°C. Few drops of methyl red 
solution were added (see appendix), examined the red colour which indicates 
positive while, yellow signifies negative (Collins and Lynes, 1989). 
Voges-proskaeur test (VP) 
ft was carried according to Baritts method. Briefly a few colonies from 
MacConkey were inoculated in 3ml of VP broth (see appendix) and inoculated 
at 37°C for 24 hours, 3ml of 5% alpha-nepthol and 3ml of 40% potassium 
hydroxide is added with vigorous shaking (Collins and Lynes, 1989). 
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Citrate test 
Simmons citrate agar (see appendix) were dispense into tubes, autoclave at 
121°C for 15 min., and cool in the slanted position. Inoculate the slant with a 
straight wire from a saline suspension of young agar culture. Incubate at 37°C 
for 4 days (Collins and Lynes, 1989). 
Urease test 
It was carried according to urea agar based, Christensen's methods (appendix). 
pH was adjusted to 6.8 and sterilized by filtration. 2.0 gm of agar were 
dissolved in 900 ml of distilled water, and autoclaved at 121°C for 15 min. It 
was cooled to 55 °C in a water bath and added 100 ml of sterile urea 
concentrated. Slants were cooled in a slanted position with buts. Few colonies 
from MacConkey were inoculating heavily over the entire surface of the slant, 
and incubate at 37°C. Examine at 2 and 4 hours and after overnight incubation 
(Ananthanarayna and Paniker, 1997). 
Oxidase test 
Oxidases were carried according to Hugh and Leifson test method (see 
appendix). Cultures were incubated on nutrient agar slopes for 24-48 hours at 
the optimum temperature for the strain concerned. Few drops of 1% aqueous 
/?-aminodimethylaniline oxalate and 1% a-napthol in ethanol were added. 
Allow the mixture to run over the growth (Ananthanarayna and Paniker, 1997). 
Nitratase test (nitrate reduction) 
One tube of nitrate broth with test sample and other is controlled were 
inoculated and incubated at 37°C for 48 hours. Nitrate reduction test solution 
A, 1 ml and 1 ml solution B in 5 ml of culture of each test sample were added 
of each tube. Saked the tube and watched for the development of colour 
(Albert, e^.a/.,1991). 
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'l(fsuCts 
This study was carried out on the samples isolated from NICU of a large 
teaching hospital of JNMC, Aligarh over a one-year period. This hospital 
caters to patients from low socio-economic status. It is a 1300 bedded hospital 
with 90 beds allotted to pediatric patients. The NICU has 20 beds. Inspite of 
small NICU, patients' turnover is quite high. Gram-negative bacilli are 
frequently associated with NIs in NICU patients, particularly ventilator-
associated pneumonia and catheter-associated urinary tract infection. During 
one-year study period from January 2006 to February 2007, samples were 
collected from different sources like; Blood, Catheter, Urine, Surface, Eyelid, 
Mouth, cerebrospinal fluid (CSF), Pus and envkonmental isolates (Table-1, 2, 
and 3). These samples were characterized on the basis of morphology (NB, 
BHI, and EMB agar), gram staining, motility and capsule staining through 
different types of chemical and finally they were grown on MacConkey agar. 
E.coli were identified as non capsulated, motile, circular, convex, and smooth 
colonies, where as Klebsiella appeared as large pink colonies, very mucoid, 
capsulated, and non-motile. On the other hand, Pseudomonas were motile and 
rods, which produce, water soluble green or yellow green (fluorescing) 
pigments. These clinical isolates were fiirther characterized by standard 
biochemical tests. 
During the period of one year, a total of 3513 neonates were screened 
for the nosocomial infection in the NICU. Among these 3513 of neonates 
973(27.69%) were found to have clinically suspected cultures. While 30.72% 
(299/973) of them were positive for neonatal infection (Table 1, 2, &3). Of 
271, 178 (65.68%) neonatal sepsis were found to comprise of 26.93%, 14.39%, 
10.70%, 8.85%, 2.58% 2.21%, UTI, septicemia, conjunctivitis, throat. Pus, and 
meningitis infection respectively. Among 271 isolates, 66 (24.35%) cases of 
intracath and 27 (9.96%)) surface culture were found. The causative organisms 
of intracath and surface culture were found to be predominantly, Klebsiella 
followed by E.coli and Pseudomonas spp (Table 4). 
Of, 271 confirmed isolates of neonatal infection, 27.30% (74/271) were 
confirmed as E.coli, 191 (70.74%) were Klebsiella spp and 6 (2.21%) were 
Pseudomonas spp (Table 4). Moreover, the study also revealed that a total of 
186 neonates out of 271 (68.63%)) were categorized as very low birth weight 
babies (<1500g) where as 85 of them were belong to the low birth weight 
babies (>1500g <2.5g). A total of 164 (60.51%) cases of preterm babies (<37 
weeks) were found in this study (164/271), remaining were full term (>37 
weeks) babies (39.48%) as shown in table 5. We have also screened the 
environmental sample collected from different sites of NICU (ventilator, 
radiant wormer, photo therapy, cot, stethoscope, refrigerator, and weighing 
machine) and were found to have 28 (9.36%o) isolates of E.coli, Klebsiella and 
Pseudomonas spp (Table 6). 
The results of present study showed that among the preterm babies 
51.35% (38/74) isolates were E.coli positive. These 38 isolates were 
distributed among preterm babies during their early onset sepsis, 60.52% 
(23/38) and late onset sepsis, 39.47% (15/38) (Table 7). Where as screening of 
full term babies revealed the occurrence of 36 E.coli isolates. Of these 36, 21 
(58.33%) E.coli isolate were found during early onset sepsis and 15 (41.66%) 
were present in the late onset sepsis (Table 8). Of 74, a total of 41 (55.40%) 
E.coli isolates were found among the male babies where as 33 (44.59%) were 
present in the female neonates. Of 41 E.coli isolates, 20 (48.78%) E.coli 
isolates were found among the preterm babies where as 21 (51.21%) E.coli 
isolates were present among the full term babies (Table 7«&8). Of 33 E.coli 
isolates among the female, 18 (54.54%)) E.coli isolates were detected among 
the preterm babies while 15 (45.45%)) Ecoli isolates were present in the full 
term babies. Our study further revealed that among the male preterm babies, 
60.86% infections were observed during early onset sepsis and 26.08% in the 
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late onset sepsis. Moreover, 39.13% infections were found in the early and late 
onset sepsis of female preterm babies. 
Our study also revealed that among the preterm babies, 63.87% 
(122/191) Klebsiella spp isolates were found. These 122 isolates were 
distributed among preterm babies during their early onset sepsis 68.03% 
(83/122) and late onset sepsis 31.96% (39/122) (Table 9). Whereas, screening 
of full term babies revealed the occurrence of 69 Klebsiella spp isolates (Table 
10). Of these 69, 42 (60.86%) Klebsiella spp were found to be during early 
onset and 27 (39.13%) were in the late onset sepsis. Of 191, a total of 96 
(50.26%) Klebsiella spp isolates were found among the male neonates where 
as 95 (49.73%) were present in the female neonates (Table 9&10). Of 96 
Klebsiella isolates, 64 (66.66%) Klebsiella spp isolates were found among the 
preterm babies where as 32 (33.33%) Klebsiella spp were present among the 
full term babies. Of 95 (49.73%) Klebsiella spp isolates, 58 (61.05%) 
Klebsiella spp were detected among the preterm babies (Table 9) while 37 
(38.94%) Klebsiella spp isolates were present in the full term babies (table 10). 
Our study further revealed that among the male preterm babies, 56.62% 
infections were observed during early onset sepsis and 43.58% in the late onset 
sepsis. Moreover, 43.37% infections were found in the early and 56.41% in 
late onset sepsis of female preterm babies. 
Our data showed that among the preterm babies, 66.66% (4/6) 
Pseudomonas spp isolates were found. Of these 4 isolates, were distributed 
among preterm babies 3 were found during their early onset sepsis 75% (3/4) 
and 25% during late onset sepsis (Table 11). Where as, screening of full term 
babies revealed the occurrence of 2 (33.33%») Pseudomonas spp isolates 
(Table 12). These 2 Pseudomonas spp were found to be present during early 
onset sepsis and no strains were detected in the late onset sepsis. Out of two 
21 
isolates one was male and other was a female baby among the early onset 
sepsis. 
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M : Male 
F : Female 
+ : Positive result. 
: Negative results 
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.Continued) 
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Table-2 Morphological and Biochemical Characterization of Clinical Isolates 
Klebsiella 
o 
e 
(y5 
336 
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34S 
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4-
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+ 
+ 
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* 
+ 
+ 
+ 
+ 
M 
F 
+ 
-
V 
N 
: Male 
: Female 
: Positive result. 
: Negative results 
: Variable 
: Non-motile 
CSF: Cerebro spinal fluid 
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Table-3 Morphological and Biochemical Characterization of Clinical 
Isolates 
o 
a 
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Urine 
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+ 
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+ 
M : Male 
F : Female 
+ : Positive result. 
: Negative results 
Mo: Motile 
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Table-4 Percent occurrence of different microorganism found at different 
sites of infection of neonates in NICU 
Type of 
culture 
Urine 
Blood 
Eyelid 
Throat 
Pus 
CSF 
Catheter tip 
Surface 
Total 
No (%) of 
E.con 
18(24.65) 
10(25.64) 
8(27.58) 
10(41.66) 
3(42.85) 
2(33.33) 
14(21.21) 
9(33.33) 
74(27.30) 
No (%) of 
Klebsiella 
52(71.23) 
29(74.35) 
21(72.41) 
14(58.00) 
4(57.14) 
4(66.66) 
50(75.75) 
17(62.96) 
191(70.47) 
No (%) of 
Pseudomonas 
3(4.10) 
-
-
-
-
-
2(3.30) 
1(3.70) 
6(2.21) 
No (%) of 
Total 
73(26.93) 
39(14.39) 
29(10.70) 
24(8.85) 
7(2.58) 
6(2.21) 
66(24.35) 
27(9.96) 
271(100) 
CSF: Cerebro spinal fluid 
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Table-5 Percent occurrence of different microorganism found in NICU 
with reference to the age and sex of the patients. 
Gestational age 
No (%) of Preterm 
No (%) of Term 
Onset sepsis 
No (%) of early 
No(%)oflate 
Birth weight 
No(%)of<1500g 
No(%)of>1500g 
Sex 
No(%)ofM 
No(%)ofF 
E.coli 
38(23.17) 
36(33.64) 
44(25.28) 
30(30.92 
47(25.26) 
27(31.76) 
41(29.49) 
33(25.00) 
Klebsiella 
122(74.39) 
69(64.48) 
125(71.83) 
66(86.04) 
134(72.04) 
57(67.05) 
96(69.06) 
95(71.96) 
Pseudomonas 
4(2.43) 
2(1.86) 
5(2.87) 
1(1.03) 
5(2.68) 
1(22.35) 
2(1.43) 
4(3.03) 
Total 
164(100) 
107(100) 
174(100) 
97(100) 
186(100) 
85(100) 
139(100) 
132(100) 
Preterm 
Term 
Early onset sepsis 
Late onset sepsis 
M 
F 
:< 37 weeks 
:>37 weeks 
:0-5 days 
:5-28 days 
:Male 
:Female 
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Table-6 Spread of nosocomial infection through environment 
Type of sample 
Ventilator 
Radiant Wormer 
Photo therapy 
Cot (palna) 
Stethoscope 
Refrigerator 
Weighing machine 
Total 
No (%) of 
E.coli 
1(9.09) 
2(18.18) 
2(18.18) 
3(27.27) 
-(0.00) 
-(0.00) 
3(27.27) 
11(100) 
No (%) of 
Klebsiella 
2(16.66) 
1(8.33) 
3(25.00) 
2(16.66) 
1(8.33) 
1(8.33) 
2(16.66) 
12(100) 
No (%) of 
Pseudomonas 
-(0.00) 
2(40.00) 
1(20.00) 
1(20.00) 
-(0.00) 
-(0.00) 
1(20.00) 
5(100) 
Total No (%) 
of pathogens 
3(10.71) 
5(17.85) 
6(21.42) 
6(21.42) 
1(3.57) 
1(3.57) 
6(21.42) 
28(100) 
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Table-7 Infection of E.coli in preterm babies 
E 
«"s 
io 
S2 
o 
Blood 
Catheter 
Urine 
Surface 
Eyelid 
Throat 
CSF 
Pus 
Total 
is u 
04(17.39) 
05(21.73) 
04(17.39) 
03(13.04) 
01(4.34) 
04(17.39) 
01(4.34) 
01(4.34) 
23(100) 
0 
11 
3(21.24) 
2(14.28) 
3(21.24) 
2(14.28) 
-(0.00) 
2(14.28) 
1(7.14) 
1(7.14) 
14(100) 
Preterm 
0 
0 a 
Z tS 
1(11.11) 
3(33.33) 
1(11.11) 
1(11.11) 
1(11.11) 
2(22.22) 
-(0.00) 
-(0.00) 
9(100) 
W IB 
Z ^ ^ 
02(13.33) 
02(13.33) 
01(6.66) 
04(26.66) 
02(13.33) 
03(20.00) 
-(0.00) 
01(6.66) 
15(100.0) 
0 
z t 
1(16.66) 
2(33..33) 
-(0.00) 
1(16.66) 
-(0.00) 
1(16.66) 
-(0.00) 
1(16.66) 
6(100) 
CM 
0 
0 S 
z a 
1(11.11) 
-(0.00) 
1(11.11) 
3(33.33) 
2(22.22) 
2(22.22) 
-(0.00) 
-(0.00) 
9(100) 
0 C <U 
06(15.78) 
07(18.42) 
05(13.15) 
07(18.42) 
03(7.89) 
07(18.42) 
01(2.63) 
02(5.26) 
38(100) 
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Table-8 Infection of E.coli in full term babies 
E 
o '3 
t a §0 
as 
t*5 
0 
V 
<u "a 
o- g 
Blood 
Catheter 
Urine 
Surface 
Eyelid 
Throat 
CSF 
Pus 
Total 
0 is a, 
z (2 S 
03(14.28) 
05(23.80) 
07(33.33) 
02(9.52) 
02(9.52) 
01(4.76) 
01(4.76) 
- (0.00) 
21(100) 
0 
0 3 
z t. 2(18.18) 
2(18.18) 
4(36.36) 
1(9.09) 
1(9.09) 
-(0.00) 
1(9.09) 
-(0.00) 
11(100) 
Full term 
0 
Z <S 
1(10.00) 
2 (20.00) 
3(30.00) 
2(20.00) 
1(10.00) 
1(10.00) 
-(0.00) 
-(0.00) 
10 (100) 
z J3 S 
01(6.66) 
02(13.33) 
06(40.00) 
-(0.00) 
03(20.00) 
02(13.33) 
-(0.00) 
01(6.66) 
15(100) 
0 
z t 
2(20.00) 
2(20.00) 
4(40.00) 
-(0.00) 
1(10.00) 
-(0.00) 
1(10.00) 
-(0.00) 
10(100) 
0 
0 S 
z <£ 
-(0.00) 
1(20.0) 
3(60.00) 
1(20.00) 
-(0.00) 
-(0.00) 
-(0.00) 
-(0.00) 
5(100) 
0 a ti 
rs 0 jj c 
04(11.11) 
07(19.44) 
13(36.00) 
02(5.55) 
05(13.88) 
03(8.33) 
01(2.77) 
01(2.770 
36(100) 
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Table-9 Infection of Klebsiella in preterm babies 
Preterm 
s 
O "= 
§ 0 
1 
it 
V fir 
Blood 
Catheter 
Urine 
Surface 
Eyelid 
Throat 
CSF 
Pus 
Total 
0 
Z uS 0 X 
10(12.04) 
24(28.91) 
25(30.12) 
06(7.22) 
08(9.63) 
07(8.43) 
01(1.20) 
02(2.40) 
83(100) 
0 
z S 
4(8.51) 
16(34.04) 
18(38.29) 
2(4.25) 
3(6.38) 
3(6.38) 
1(2.12) 
-(0.00) 
47(100) 
0 
z <& 
6(16.66) 
8(22.22) 
7(19.44) 
4(11.11) 
5(13.88) 
4(11.11) 
-(0.00) 
2(5.55) 
36(100) 
•—' U (B 
0 -a ft" 
z JS S 
12(30.76) 
07(17.94) 
13(33.33) 
02(5.12) 
03(7.69) 
01(2.56) 
01 ((2.56) 
-(0.00) 
39(100) 
CM 0 
z :? 
4(23.52) 
3(17.64) 
8(47.05) 
1(5.88) 
1(5.88) 
-(0.00) 
-(0.00) 
-(0.00) 
17(100) 
CM 
0 
Z cS 
8(36.36) 
4(18.18) 
5(22.77) 
1(4.54) 
2(9.09) 
1(4.54) 
1(4.54) 
-(0.00) 
22(100) 
22(18.03) 
31(25.40) 
38(31.14) 
08(6.55) 
11(9.01) 
08(6.55) 
02(1.63) 
02(1.63) 
122(100) 
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Table-10 Infection of Klebsiella in full term babies 
ll 
1 
o 
it 
at a. 
Blood 
Catheter 
Urine 
Surface 
Eyelid 
Throat 
CSF 
Pus 
Total 
0 
05(11.90) 
13(30.95) 
09(21.42) 
06(14.28) 
04(9.52) 
03(7.14) 
01(2.38) 
01(2.38) 
42(100) 
0 
Z % 
2(9.09) 
5(22.77) 
5(22.77) 
2(9.09) 
1(5.88) 
1(5.88) 
- (0.00) 
1(5.88) 
17(100) 
Full term 
0 
z <a 
3(12.00) 
8(32.00) 
4(16.00) 
4(16.00) 
3(12.00) 
2(8.00) 
1(4.00) 
-(0.00) 
25(100) 
^ 0 .2 
z J3 S 
02(7.40) 
06(22.22) 
05(18.51) 
03(11.11) 
06(22.22) 
03(11.11) 
01(3.70) 
01((3.70) 
27(100) 
0 
z :? 
-(0.00) 
4(26.66) 
2(13.33) 
2(13.33) 
4(26.66) 
1(6.66) 
1(6.66) 
1(6.66) 
15(100) 
0 
0 S 
Z ^ 
2(16.66) 
2(16.66) 
3(25.00) 
1(8.33 
2(16.66) 
2(16.66) 
-(0.00) 
-(0.00) 
12(100) 
0 i) 
07(10.14) 
19(27.53) 
14(20.28) 
09(13.04) 
10(14.49) 
06(8.69) 
02(2.89) 
02(2.89) 
69(100) 
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Table-11 Infection of Pseudomonas in preterm babies 
o 'S E. « 
S 0 
1 
s 
•§ 
a 
Blood 
Catheter 
Urine 
Surface 
Eyelid 
Throat 
CSF 
Pus 
Total 
0 
? a-. -^  -2 
0 is fi S-
Z w 0 " 
-(0.00) 
1(33.33) 
2(66.66) 
-(0.00) 
-(0.00) 
-(0.00) 
-(0.00) 
-(0.00) 
3(100) 
CM 0 
-(0.00) 
-(0.00) 
1(100.0) 
-(0.00) 
-(0.00) 
-(0.00) 
-(0.00) 
-(0.00) 
1(100.0) 
Preterm 
0 
0 H 
-(0.00) 
1(50.00) 
1(50.00) 
-(0.00) 
-(0.00) 
-(0.00) 
-(0.00) 
-(0.00) 
2(100.0) 
^ 0 .2 
0 5 (^  
z 2 ^ 
-(0.00) 
1(100.0) 
-(0.00) 
-(0.00) 
-(0.00) 
-(0.00) 
-(0.00) 
-(0.00) 
1(100) 
0 
z S 
-(0.00) 
-(0.00) 
-(0.00) 
-(0.00) 
-(0.00) 
-(0.00) 
-(0.00) 
-(0.00) 
-(0.00) 
CM 
0 
0 S 
Z c2 
-(0.00) 
1(100.0) 
-(0.00) 
-(0.00) 
-(0.00) J 
-(0.00) 
-(0.00) 
-(0.00) 
1(100.0) 
s cT 15 
-(0.00) 
2(50.00) 
2(50.00) 
-(0.00) 
-(0.00) 
-(0.00) 
-(0.00) 
-(0.00) 
4(100) 
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Table-12 Infection of Pseudomonas in full term babies 
E 
S O 
1 
Blood 
Catheter 
Urine 
Surface 
Eyelid 
Throat 
CSF 
Pus 
Total 
0 
0 1 c S-
-(0.00) 
-(0.00) 
1(50.00) 
1(50.00) 
-(0.00) 
-(0.00) 
-(0.00) 
-(0.00) 
02(100) 
] 
0 
z S 
-(0.00) 
-(0.00) 
1(100.0) 
-(0.00) 
-(0.00) 
-(0.00) 
-(0.00) 
-(0.00) 
1(100.0) 
Pull term 
0 
0 & 
Z ^ 
-(0.00) 
-(0.00) 
1(100.0) 
-(0.00) 
-(0.00) 
-(0.00) 
-(0.00) 
-(0.00) 
1(100.0) 
^ 0 .2 
z J S 
-(0.00) 
-(0.00) 
-(0.00) 
-(0.00) 
-(0.00) 
-(0.00) 
-(0.00) 
-(0.00) 
-(0.00) 
0 
> ^ 
v= 
©^ CJ 
z S 
-(0.00) 
-(0.00) 
-(0.00) 
-(0.00) 
-(0.00) 
-(0.00) 
-(0.00) 
-(0.00) 
-(0.00) 
0 
0 a 
z t£ 
-(0.00) 
-(0.00) 
-(0.00) 
-(0.00) 
-(0.00) 
-(0.00) 
-(0.00) 
-(0.00) 
-(0.00) 
0 a> 
-(0.00) 
-(0.00) 
1(50.00) 
1(50.00) 
-(0.00) 
-(0.00) 
-(0.00) 
-(0.00) 
2(100) 
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(Discussion 
This study was carried out on the samples isolated from NICU of a large 
teaching hospital of JNMC, AMU., Aligarh over a one-year period from 
January 2006 to February 2007. This hospital provides services to patients 
from low socio-economic status. 
A total 299 neonates were found to have infection during the stay in 
microorganism causing infection were identified on the basis of morphology. 
Gram staining, motility and capsule staining, through different types of 
chemical. E.coli are non capsulated, motile, circular, convex, and smooth 
colonies where as Klebsiella appears as large pink colonies, very mucoid, 
capsulated, non-motile on the other hand Pseudomonas are motile, rods which 
produce water soluble green or yellow green (fluorescent) pigments. These 
clinical isolates were further characterized by standard biochemical tests. 
The overall infection rate was 27.69% (973/3513) among all admissions 
during our study period (Townsend, 2002). This infection 29.86 % rate was 
also reported by other workers (Khadilkar, et.al, 1995). Neonates with birth 
weight less then 1500g have the highest possibility of acquiring NI (68.26%) 
whereas those with birth weight greater then 1500g showed the lowest rate 
(31.36%). Our data was consistent to the other studies (Schmidt, et.al, 1987). 
(Soman et al 1985) in which 83%) neonates with low birth weight were 
observed to have sepsis (Table-5). Low birth weight has been found to be a 
great risk factor for nosocomial infection (Gaynes, et.al.,\996, Nambiar, 2002 
and Thompson, et.al 1992). The main reasons are premature immune systems 
of low birth weight neonates, dependence on invasive intervention therapies, 
and extended exposure to broad-spectrum antimicrobials in low birth weight 
neonates (Zafar, et.al., 2001 and Waterer, et.al., 2001). Cell mediated 
immunity is greatly suppressed in malnourished children had a higher 
incidence of NI which corroborates with the study by (Isaack, et. al., 1992). A 
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group of researcher has reported that VLBW neonates with mutation in 
specific CD 14 gene have got a greater rate of neonatal sepsis than those 
without mutation is CD 14 (Ahrens, et. al, 2004 Sohn, et. al, 2001). A 
different method of assessment of nosocomial bloodstream infection (NBSI) in 
low birth weight neonates was used in this study. Neonate with birth 
weight<750 g had the highest possibility of acquiring NBSI whereas, those 
with birth weight between 1250 g and 1499 g showed the lowest rate. Patient 
with birth weight<1500 g got a higher NBSI rate then those with weight 
>1500g (5.00 vs 1.50 per 1000 patient-days) The results are comparable to 
other studies (Raymond, et. al, 2000 and Cordero, et. al, 1999). 
There were 174 (64.20%) cases of early and 97 (35.79%) of late onset 
sepsis were detected in our study. We found that early onset sepsis is more 
common than late onset sepsis, which is comparable to the reports from the 
other developing countries (Fisher, et.al, 1983 and Gladstone, et.al, 1990), 
but in contrast, the report from Bangladesh showed that late onset sepsis was 
more common then early onset sepsis (Ahmad, et.al, 2002). Sepsis is generally 
considered to be the result of various risk factors both maternal and neonatal 
such as prematurity, low birth weight, hyaline membrane disease, small 
gestational age, prolonged amniotic membrane rupture of the mother, birth 
defect and asphyxia (Hambraeus, et.al, 1999, Rojo et.al, 1999, Sader et.al, 
1997 and Leroyer et.al, 1997). No uniform criteria have yet been established 
for sepsis screening for infants at risk of early onset sepsis. Cut off values for 
prolonged rupture of amniotic membranes have varied between 12 to 24 hours 
(Chacko and Sohi 2005). In this study, birth weight was taken as one of the 
criterion, into consideration for screening. Maternal risk factors were observed 
as 68.26% in the present study, in contrast to 30% were reported from South 
Indian group (Archibald, et.al, 1997). This could be explained by the fact that 
ours being a tertiary care institution, constitute ~ 40% of deliveries. 
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Prematurity and rupture of membranes for more than 18 hours before delivery 
are major risk factors, reported by Oddie et. al, (1997). 
The causative microorganisms in the present study were similar to the 
finding of other groups in India where Klebsiella spp is the most common 
organism 191(70.47%) followed by E.coli 74 (27.30%) and Pseudomonas 6 
(2.21%) Similar patterns have been reported in the earlier studies (Yimion, et 
al, 2002 and Drews, et al, 1996). 
The current study regarding nosocomial urinary tract infection, the most 
common infection is mainly focused on, related risk factors (Al-Helali, et.al, 
2004), and recommendation to reduce the nosocomial urinary tract infection 
rate at JNMC, Aligarh (Table-4). The finding of the current study could be a 
reflection of these suggestions viz: shorter duration of catheter use, more 
attention to catheter hygiene, increased antibiotic use etc. 
The chance of microbial infection in the bladder, either during the 
procedure of catheterization or migration between the external catheter surface 
and the urethral epithelium, are more common (Mulhall, et.al, 1988). 
Moreover, this chance of infection is increased, if the catheter is left in situ for 
more than 5 days (Kunin and McCormack, et al, 1996). 
The present study did not show any significant difference in the 
incidence of catheter related infections in male and female due to the use of 
catheters tip (Darbyshire, et al, 1985, Narendaran, et al, 1996). 
One study revealed that NIs rate is strongly correlated with patients' 
density (Khalid, et.al, 2005). Over crowding may also contribute to the 
outbreak of Enterobacteriace (Harbarth, et.al, 1999). Although there is only 
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limited data to support the role of over crowding in the NIs. Possible 
explanations for the relationship above, may be poor aseptic practice 
associated with increased workload and inadequate sterilization of devices. 
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ConcCvsion 
Critically ill patients of NICU are at particular risk for developing NI. It is 
important to know the pathogen causing infection in the NICU to formulate 
appropriate treatment guidelines. We conducted this study from January 2006 
to February 2007 in the NICU in JNMC, AMU., Aligarh. The causative 
organisms of intracath and surface were foimd to be predommantly, Klebsiella 
followed by E.coli and Pseudomonas spp. Of, 271 confirmed isolates of 
neonatal infection, 27.30% (74/271) were confirmed as E.coli, 191 (70.74%) 
were Klebsiella spp and 6 (2.21%) were Pseudomonas spp. There were 174 
(64.20%) cases of early and 97 (35.79%) of late onset sepsis were detected in 
our study. Moreover, the present study also revealed that a total of 186 
neonates out of 271 (68.63%) were categorized as very low birth weight babies 
where as 85 of them were belonged to the low birth weight babies. A total of 
164 (60.51%) cases of preterm babies were found in this study (164/271), 
remaining were full term babies (39.48%). We have also screened the 
environmental sample collected from different sites of NICU and were found 
to have 28 (9.36%) isolates oi E.coli, Klebsiella and Pseudomonas spp. These 
findings are suggestive of setting new preventive sfrategies and guidelines for 
handling catheter, mechanical ventilation in the critical care wards along with 
implementation of strict hospital infection control guidelines in JNMC, AMU., 
Aligarh. Besides, VLBW and preterm babies being the prime cause of Nl 
suggests that new strategy should be developed to reduce the same. So the use 
of collaborative quality improvement strategies seems to be necessary to 
reduced the infection in neonatal intensive care unit. Secondly, the factors 
responsible for the morbidity and mortality of higher birth weight, preterm and 
ftillterm babies still remain to be risk factors as this study was limited for the 
risk factors in VLBW neonates. Therefore, further studies are suggested to 
determine the probable factors responsible for causality of HBW neonates in 
NICU as well as to search the critical analysis of the risk factors at the 
molecular level. 
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Appencfba 
1.Brain heart infusion broth 
Calfbrain, infusion from I2.5gms 
Beef heart, infusion from 5 gms 
Proteose pancreatic digest of gelatin 10.0 gms 
Glucose 2gms 
Sodium chloride 5.0 gms 
Sodium phosphate 0.5 gms 
Distilled water 1 litre 
pH 7.4 
l.MacConkey Agar 
Peptone 2.0 gms 
Sod.taurocholate 0.5gms 
Sod.chloride 0.5gms 
Lactose 1.0 gms 
Agar powder 2.0 gms 
Neutral red (1 % soln) 0.3 gms 
Distilled water 100 ml 
3.Nutrient Broth 
Peptone 1.0 gms 
Sodium chloride O.Sgms 
Meat extracts 100 ml 
4.Eosin-methyIene blue (EMB) 
Peptone lOgms 
Lactose 5gms 
Sucrose Sgms 
Dipotassium phosphate 2gms 
56 
Agar 13.5gms 
Eosin Y 0.4 gms 
Methylene blue 0.065gms 
Distilled water 1000ml 
S.Gram stain 
a) Crystal violet: Crystal violet, 90% dye lOgms 
Methyl Alcohol 500ml 
b) Gram iodine: Iodine Crystal Igms 
Potassium iodide 2gms 
Distilled water 300ml 
Ground the dry iodine and potassium iodide in a mortar. Added few ml of 
water at a time and ground it thoroughly, after each addition until solution is 
achieved. The solution was rinsed into an amber glass bittle with remainder of 
distilled water. 
c) Counter stain: Safranine 95% dye lOgms 
Distilled water 1000ml 
6.Peptone water 
Peptone Igms 
NaCl 0.5gms 
Distilled water 100 ml 
T.GIucose phosphate peptone water 
Peptone 0.5gms 
Potassium phosphate (K2HP04) 0.5gms 
Glucose 0.5gms 
Distilled water 100 ml 
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S.Sugar medium 
Solution A 
Sugar solution 
Solution B 
Peptone 
10% 
100 ml 
9.Andrade's indicator 
0.5% of aqueous solution of acid fuschin 
NNaOH 
pH of solutions 
100ml 
16ml 
7.4 
lO.Indole test 
Ether solvent 
Ehrlich's reagent: 
Para-dimethyl amino-benzaldehyde 
Absolute alcohol 
Hydrochloric acid (pure) 
Dissolve aldehyde in alcohol and add acid. 
4gms 
180ml 
80ml 
ll.Methyl red test 
Methyl red 
95%alcohol 
Distill water 
Dissolve indicator in alcohol and add water. 
0.1 gm 
300ml 
200ml 
ll.Voges-proskauer test 
a)a-nepthol 
Ethyl alcohol 
b)Potassium hydroxide 
Distilled water to 
5gms 
100ml 
40gms 
100ml 
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Dissolved Potassium hydroxide in 70 ml distil water in boiling flask, allow to 
cool and make up the volume to 100ml with distilled water. 
O.Citrate test (Simmons citrate agar) 
Sodium citrate 
Sodium chloride 
Magnesium sulfate 
Monoammonium phosphate 
Dipotassium phosphate 
Agar 
Bromothymol blue 
Distilled water 
pH 
14.Urea's test (Christensen's 
Solution A 
Peptone 
Glucose 
Sodium chloride 
Mono potassium Phosphate 
Phenol red 
Agar 
Distilled water 
Solution B 
Urea 
Distilled water 
pH 
i Medium) 
0.5gms 
1 .Ogms 
0.2gms 
l.Ogms 
1 .Ogms 
2.0gms 
0.08gms 
1000ml 
6.9 
0.1 gms 
0.1 gms 
O.Sgms 
0.2gms 
0.0012gms 
2.Ogms 
100ml 
2.00gms 
100ml 
6.8 
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15. Oxidase test (Hugh and Leifson medium) 
Peptone 2.0 gms 
Sodium chloride 5.0gms 
Dipotassium hydrogen phosphate 0.3gms 
Agar 3.0gms 
Distilled water 1000ml 
pH 7.1 
Heat to dissolve, adjust to 7.1 and add 15 ml of 0.2% bromothymol blue and 
sterile (filtered) glucose to give a final 1 % concentration. Dispense aseptically 
in narrow (less than 1 cm) tubes in 8-10ml amounts. 
16. Nitrate reduction test 
Solution A 
Sulphanilic acid 8gms 
Acetic acid 5N (one part glacial acetic 
acid to 2.5 parts water) 1000ml 
Soiution B 
a-Nepthylamine 5 gms 
Acetic acid (5N) 1000 ml 
Dissolved reagents in acetic acid with gently heating and shaking. 
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